dsip portal Capturing Non-Dilutive Funding from Department

Quality documentation Third-party tested batch-specific results 99.9%purity Batch COA PDF not linked yet for this variant

Both are commonly compared in bio-hacking communities because theyre both synthetic, intranasally administered, and target the central nervous system to improve mental performance, all the while offering very distinct benefits

PMID 12354393

The results reported in Huntingtons disease from a randomized, placebo-controlled study, which examines both efficacy and safety of MEM during long-term administration (52 weeks) in non-demented multiple sclerosis patients, were negative for cognitive impairment improvement